Real-world studies: bridging the gap between trial-assessed efficacy and routine care
Author:
Publisher
Journal of Biomedical Research
Subject
General Biochemistry, Genetics and Molecular Biology,General Medicine
Link
http://www.jbr-pub.org.cn/fileSWYXYJZZYWB/journal/article/swyxyjzzywb/2022/3/JBR-2022-0040.pdf
Reference54 articles.
1. Bothwell LE, Greene JA, Podolsky SH, et al. Assessing the gold standard-lessons from the history of RCTs[J]. N Engl J Med, 2016, 374(22): 2175–2181.
2. Gray CM, Grimson F, Layton D, et al. A framework for methodological choice and evidence assessment for studies using external comparators from real world data[J]. Drug Saf, 2020, 43(7): 623–633.
3. Monti S, Grosso V, Todoerti M, et al. Randomized controlled trials and real-world data: differences and similarities to untangle literature data[J]. Rheumatology, 2018, 57(57 Suppl 7): vii54–vii58.
4. Beaulieu-Jones BK, Finlayson SG, Yuan W, et al. Examining the use of real-world evidence in the regulatory process[J]. Clin Pharmacol Ther, 2020, 107(4): 843–852.
5. Chen D, Qi EY. Innovative highlights of clinical drug trial design[J]. Transl Res, 2020, 224: 71–77.
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Short-term efficacy of vedolizumab in patients with inflammatory bowel disease in real-life settings in Bosnia and Herzegovina;Biomolecules and Biomedicine;2024-09-06
2. Real-World Efficacy of Intravitreal Faricimab for Diabetic Macular Edema: A Systematic Review;Journal of Personalized Medicine;2024-08-28
3. Revolutionizing Immunotherapy: Unveiling New Horizons, Confronting Challenges, and Navigating Therapeutic Frontiers in CAR-T Cell-Based Gene Therapies;ImmunoTargets and Therapy;2024-08
4. Real-world efficacy of intravitreal faricimab for neovascular age-related macular degeneration: a systematic review;International Journal of Retina and Vitreous;2024-07-12
5. Implementation of perioperative FLOT compared to ECX/EOX chemotherapy regimens in resectable esophagogastric adenocarcinomas: an analysis of real-world data;Acta Oncologica;2024-05-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3